3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
66
Lymphoma, Large B-Cell, Diffuse
48
Lymphoma
34
Burkitt Lymphoma
28
Lymphoma, Follicular
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
14
Lymphoma, Non-Hodgkin
14
Lymphoma, B-Cell
12
Lymphoma, T-Cell, Peripheral
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Hodgkin Disease
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia
7
Recurrence
6
Prostatic Neoplasms, Castration-Resistant
6
Multiple Myeloma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Neoplasm Metastasis
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Anaplastic
4
Immunoblastic Lymphadenopathy
4
Ovarian Neoplasms
3
Myasthenia Gravis
3
Metastatic Castration-resistant Prostate Cancer
3
Melanoma
3
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Prednisone
×
1 year
×
Clear all
No trials found.